[Commentary on] Should we screen for bladder cancer in a high-risk population? A cost per life-year saved analysis. Lotan Y, Svatek RS, Sagalowsky AI, Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX.

Detalles Bibliográficos
Publicado en:Urologic Oncology Vol. 25; no. 3; pp. 274 - 275
Autor principal: See WA
Formato: abstract commentary Journal Article
Publicado: Elsevier B.V. May2007
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105931558&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 105931558
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10781439
        JJ4
      jtl: Urologic Oncology
      issn: 10781439
      maglogo: N
    pubinfo:
      dt: May2007
      vid: 25
      iid: 3
      pid: 467
      pub: Elsevier B.V.
      place: New York, New York
    artinfo:
      ui:
        105931558
        105931558
        2009623604
        10.1016/j.urolonc.2007.03.009
        105931558
      ppf: 274
      ppct: 1
      formats:
      tig:
        atl: [Commentary on] Should we screen for bladder cancer in a high-risk population? A cost per life-year saved analysis. Lotan Y, Svatek RS, Sagalowsky AI, Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX.
      aug:
        au: See WA
      sug:
        subj:
          Bladder Neoplasms Risk Factors
          Bladder Neoplasms Therapy
          Bladder Neoplasms Diagnosis
          Cost Control
      pubtype: Academic Journal
      doctype:
        abstract
        commentary
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N